Akeso lung cancer drug trial raises hopes in US$20b market
- Posted on June 1, 2026
- By South China Morning Post
- 0 Views
- 1 min read
Akeso lung cancer drug trial raises hopes in US$20b market
Ivonescimab phase three trials reduce death risk by 34 per cent, as analysts predict it could transform non-small cell lung cancer therapy.
